Usefulness and limits of transabdominal ultrasonography for pancreatic diseases

Usefulness and limits of transabdominal ultrasonography for pancreatic diseases - Usefulness and limits of transabdominal ultrasonography for pancreatic diseases

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009285

Enrollment

Registered

2012-11-08

Start date

2012-07-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary tract system and pancreas disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients with biliary or pancreatic disease performed MDCT or EUS at Nagoya University Hospital. 2)Patients with MDCT or EUS within three months. 3)20-80 years of age. 4)Performance Status 0-1. 5)no sever organ dysfunction. 6)Patients who provided written informed consent.

Exclusion criteria

Exclusion criteria: 1)uncontrolable infection. 2)Case having the sever drug allergy including contrast. 3)Patients with liver cirrhosis, splenomegalia,ascites. 4)Patients with a pacemaker, implantable cardioverter-defibrillator. 5)Post abdominal surgery 6)Difficulty with receiving examination. 7)Patinets with sever impairment. 8)Possibility of the pregnancy 9)Patinets with sever mental disorder 10)Patinets judged as inappropriate by attendant doctor

Design outcomes

Primary

Measure	Time frame
To clarify the limits of transabdominal ultrasonography for pancreatic unobservable area	—

Countries

Japan

Contacts

Public ContactHajime Sumi

Nagoya University Hospital Department of Gastroenterology

sumi-h@med.nagoya-u.ac.jp052-744-2602

Outcome results